BackGW Pharmaceuticals Overview

GW Pharmaceuticals Cost of Revenue

Cost of Revenue analysis for GWPH.

Quarterly Cost of Revenue

$11.81M
↑ 9.64% YoY

As of Mar 31, 2021

Annual Cost of Revenue (TTM)

$38.57M
↑ 17.46% YoY

Trailing 12 months ending Mar 31, 2021

Average Cost of Revenue (Comparison Companies)

Cost of Revenue History

Cost of Revenue Comparison

Annual Cost of Revenue Growth Rate (%)

Annual Cost of Revenue Growth (Absolute)

Jump to metric
Total RevenueCost of RevenueGross ProfitResearch & DevelopmentSelling, General & AdminOperating IncomeOther Income Expense NetEBITIncome TaxNet IncomeProfit Margin